The SOD1 gene Therapy for ALS project to receive more support

The SOD1 gene therapy for ALS project, http://len.epfl.ch/page-26338-en.html, that ReMedys accompanies, has received form the Wyss center for Bio and Neuroengineering (wysscenter.ch), significant support on the path through preclinical development.